SCHEMBL6912197

SCHEMBL6912197

CC(O)COc1ccc(N)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.64
TDP1 Q9NUW8 7/20 0.55
TSHR P16473 3/20 0.54
APP P05067 1/20 0.45
ADRB2 P07550 2/20 0.44
ADRB1 P08588 2/20 0.44
ADRB3 P13945 1/20 0.44
MAPT P10636 2/20 0.43
MAPK1 P28482 1/20 0.43
POLB P06746 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
GAA P10253 1/20 0.42
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PTGS1 P23219 1/20 0.42
SLC6A2 P23975 1/20 0.42
CYP3A4 P08684 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5949941 0.89 LMNA (0.78) LMNATDP1TSHRADRB2ADRB1
SCHEMBL24352243 0.83 LMNA (0.64) LMNAMAPTMAPK1POLBNPSR1
SCHEMBL22481875 0.83 LMNA (0.64) LMNAMAPTMAPK1POLBNPSR1
SCHEMBL24352249 0.83 LMNA (0.64) LMNAMAPTMAPK1POLBNPSR1
SCHEMBL6141129 0.83 TDP1 (0.52) LMNATDP1TSHRAPPADRB2
SCHEMBL7934862 0.83 MAPT (0.55) LMNATDP1TSHRAPPADRB2
SCHEMBL109648 0.83 TDP1 (0.64) LMNATDP1TSHRAPPMAPT
SCHEMBL14407437 0.83 TDP1 (0.59) LMNATDP1TSHRAPPMAPT
SCHEMBL9452308 0.81 TDP1 (0.49) LMNATDP1TSHRAPPADRB2
SCHEMBL14570065 0.81 LMNA (0.67) LMNATSHRMAPTPOLBNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109641832-B Azo compounds, polymers, and methods of preparation and use 东莞东阳光医疗智能器件研发有限公司 2021-06-08 CN disclosed
US-6689899-B2 HYDROGENATION OF THE CORRESPONDING DINITRO COMPOUNDS KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2004-02-10 US disclosed
US-20020019558-A1 Diamine and acid anhydride KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2002-02-14 US disclosed
US-4036824-A Disazo dyestuffs containing A-O-alkylene-O-SO3 H group BAYER AKTIENGESELLSCHAFT (DT) 1977-07-19 US disclosed
US-3956267-A Indole-containing disazo dyestuffs having a sulfatoalkyleneoxy-substituent BAYER AKTIENGESELLSCHAFT (DT) 1976-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019558-A1 Diamine and acid anhydride CA1, ASIC1, CA4 LMNA 3713/4885TDP1 3268/4885TSHR 3875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.